Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Intelligent
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Infinitus (China) Company Ltd.
Hanon Systems
Lufax Holding Ltd